Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Red Book of Mood Disorders in Women: An Evidence-Based Treatment Guide
1
x
$
30.00
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
1
x
$
0.00
Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study
1
x
$
30.00
Jun-Sheng Wang, MD, PhD: Pharmacokinetics and Drug Interactions of the Sedative Hypnotics
1
x
$
30.00
K. Ranga Rama Krishnan, MB, ChB: Evidence-Based Mental Health
1
x
$
30.00
Letter From the Editors: Right Tool, Right Time, Right Reason
1
x
$
0.00
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
1
x
$
30.00
Long-Term Treatment Strategies in Anxiety Disorders
1
x
$
30.00
Psychopharmacotherapy of Premenstrual Dysphoric Disorder—New Vistas
1
x
$
30.00
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 37 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
60.00
View Cart
Checkout
Home
Store
You cannot add another "The Red Book of Mood Disorders in Women: An Evidence-Based Treatment Guide" to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
$
30.00
Add to cart
Details
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
$
30.00
Add to cart
Details
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
$
30.00
Add to cart
Details
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
$
30.00
Add to cart
Details
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
$
30.00
Add to cart
Details
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
$
30.00
Add to cart
Details
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
$
30.00
Add to cart
Details
Alzheimer’s and Dementia Guidelines and Tables
$
30.00
Add to cart
Details
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
$
30.00
Add to cart
Details
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
$
30.00
Add to cart
Details
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
$
30.00
Add to cart
Details
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents
$
30.00
Add to cart
Details
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
$
30.00
Add to cart
Details
Lamotrigine and Stevens-Johnson Syndrome Prevention
$
30.00
Add to cart
Details
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
$
30.00
Add to cart
Details
Antiepileptic Drugs and Bone Health: Current Concepts (OPEN ACCESS)
$
0.00
Add to cart
Details
Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital
$
30.00
Add to cart
Details
Previous
1
…
5
6
7
…
44
Next
Page load link
Go to Top
